Evolving epidemiology and improving safety of rechallenge in immune checkpoint inhibitor-associated acute kidney injury: an updated meta-analysis

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-02-24
DOI
https://doi.org/10.3389/fimmu.2026.1777744
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evolving epidemiology and improving safety of rechallenge in immune checkpoint inhibitor-associated acute kidney injury: an updated meta-analysis

D. Li, Wenge Li, Xia Gu, Yue Yang
Frontiers in Immunology
Cancer Immunotherapy and Biomarkers
article

Evolving epidemiology and improving safety of rechallenge in immune checkpoint inhibitor-associated acute kidney injury: an updated meta-analysis

D. Li, Wenge Li, Xia Gu, Yue Yang
article en

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 17
China-Japan Friendship Hospital (CN), Shandong Provincial Hospital (CN), Beijing Friendship Hospital (CN), Shandong First Medical University (CN)
Good health and well-being
Openalex Percentile: Top 42%
Cancer Immunotherapy and Biomarkers
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.